Allelic Variants
|
|
There are no related allelic variants
|
|
| Number of involved diseases in the family |
55 |
| Number of MET related diseases |
8 |
All kinase in this family
MET
Allelic
Variants |
Disease Description |
Involved kinases
(This family) |
Inhibitor of
Involved Kinases |
Search
Disease |
| n/a | Measles | JAK1, JAK2, JAK3, MAP3K7 | 1 | Link | | n/a | Toxoplasmosis | JAK1, JAK2, MAP3K7 | 1 | Link | | n/a | Leishmaniasis | JAK1, JAK2, MAP3K7 | 1 | Link | | Lung cancer | ALK, EGFR, ROS1 | 3 | Link | | n/a | Tuberculosis | JAK1, JAK2, RIPK2 | 1 | Link | | Neuroblastoma | ALK, NTRK2, NTRK3 | 3 | Link | | n/a | Epstein-Barr virus infection | JAK1, JAK3, MAP3K7 | 1 | Link | | n/a | Herpes simplex infection | JAK1, JAK2, MAP3K7 | 1 | Link | | n/a | Hepatitis C | EGFR, JAK1 | 1 | Link | | n/a | Influenza A | JAK1, JAK2 | 1 | Link | | Melanoma | EGFR, MET | 21 | Link | | n/a | Epithelial cell signaling in Helicobacter pylori infection | EGFR, MET | 21 | Link | | Gastric cancer | EGFR, MET | 21 | Link | | n/a | Choriocarcinoma | CSF1R, EGFR | 3 | Link | | n/a | Bladder cancer | EGFR | 1 | Link | | n/a | Esophageal cancer | EGFR | 1 | Link | | n/a | Oral cancer | EGFR | 1 | Link | | n/a | Leukoencephalopathy, diffuse hereditary, with spheroids | CSF1R | 3 | Link | | n/a | Cervical cancer | EGFR | 1 | Link | | Hyperinsulinemic hypoglycemia | INSR | 2 | Link | | Prostate cancer | EGFR | 1 | Link | | n/a | Laryngeal cancer | EGFR | 1 | Link | | n/a | Glioma | EGFR | 1 | Link | | Adenocarcinoma of lung | EGFR | 1 | Link | | Diabetes mellitus | INSR | 2 | Link | | Rabson-Mendenhall syndrome | INSR | 2 | Link | | n/a | Leprechaunism | INSR | 2 | Link | | Polycythemia vera | JAK2 | 1 | Link | | n/a | Budd-Chiari syndrome | JAK2 | 1 | Link | | n/a | Congenital central hypoventilation syndrome | RET | 1 | Link | | Hirschsprung disease | RET | 1 | Link | | n/a | Renal agenesis and Renal adysplasia | RET | 1 | Link | | n/a | Obesity | NTRK2 | 3 | Link | | n/a | Thyroid cancer | RET | 1 | Link | | Central hypoventilation syndrome | RET | 1 | Link | | n/a | Medullary thyroid carcinoma | RET | 1 | Link | | n/a | Popliteal pterygium syndrome | RIPK4 | 1 | Link | | n/a | Shigellosis | RIPK2 | 1 | Link | | Renal agenesis | RET | 1 | Link | | Multiple endocrine neoplasia | RET | 1 | Link | | Pheochromocytoma | RET | 1 | Link | | n/a | Alcoholism | NTRK2 | 3 | Link | | n/a | Myasthenic syndrome | MUSK | 1 | Link | | n/a | Immunodeficiencies | JAK3 | 1 | Link | | Thrombocythemia | JAK2 | 1 | Link | | n/a | Myeloproliferative disorder | JAK2 | 1 | Link | | Leukemia | JAK2 | 1 | Link | | Myelofibrosis | JAK2 | 1 | Link | | SCID | JAK3 | 1 | Link | | Renal cell carcinoma | MET | 21 | Link | | n/a | Congenital myasthenic syndrome | MUSK | 1 | Link | | Hepatocellular carcinoma | MET | 21 | Link | | n/a | Autism suseptibility | MET | 21 | Link | | n/a | Cholangiocarcinoma | MET | 21 | Link | | n/a | Malaria | MET | 21 | Link |
|